Covid-19 has shaken world markets. One question likely to be on the minds of a lot of investors right now is how economic uncertainty caused by the pandemic will continue to affect large cap shares, such as the share price of Balchem (...
BCPC — Balchem Share Price
0.000.00%
Last trade - 00:00Consumer DefensivesBalancedLarge CapHigh Flyer
- $4.85bn
- $4.87bn
- $703.64m
- 94
- 21
- 84
- 71
Momentum
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 35.7 | ||
| PEG Ratio (f) | 2.65 | ||
| EPS Growth (f) | 15.56% | ||
| Dividend Yield (f) | 0.4% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 5.45 | ||
| Price to Tang. Book | 18.48 | ||
| Price to Free Cashflow | 37.79 | ||
| Price to Sales | 6.33 | ||
| EV to EBITDA | 28.29 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 11.41% | ||
| Return on Equity | 10.92% | ||
| Operating Margin | 15.99% | ||
Financial Summary
| Year End 31st Dec | Unit | 2016 | 2017 | 2018 | 2019 | 2020 | 2021E | 2022E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 553.2 | 594.79 | 643.68 | 643.71 | 703.64 | 785.05 | 844.21 | 4.96% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | -5.79 | +14.33 | +18.89 | +4.48 | +5.84 | +35.31 | +15.56 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Health Trend(F-Score)
12345678910
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Latest News & Insights for BCPC
Profile Summary
Balchem Corporation is engaged in developing, manufacturing, distributing and marketing of specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition and industrial markets. The Company operates through three business segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products. The Human Nutrition & Health (HNH) segment provides human grade choline nutrients and mineral amino acid chelated products through this segment for nutrition and health applications. HNH segment also serves the food and beverage industry for beverage, bakery, dairy, confectionary, and savory manufacturers. Its Animal Nutrition & Health (ANH) segment provides nutritional products derived from its microencapsulation and chelation technologies in addition to basic choline chloride. The Specialty Products segment sells ethylene oxide as a sterilant gas primarily for use in the healthcare industry.
Directors
- Theodore Harris CHM (56)
- Martin Bengtsson CFO (42)
- James Hyde SVP
- William Backus CAO (54)
- Mark Stach GCN (58)
- John Televantos LED (68)
- Kathleen Fish DRC
- David Fischer IND (58)
- Daniel Knutson IND (64)
- Joyce Lee IND (48)
- Perry Premdas IND (68)
- Matthew Wineinger IND (54)
- Last Annual
- December 31st, 2020
- Last Interim
- September 30th, 2021
- Incorporated
- January 30th, 1967
- Public Since
- June 3rd, 1986
- No. of Shareholders
- 69
- No. of Employees
- 1,305
- Sector
- Food & Tobacco
- Industry
- Consumer Defensives
- Exchange
- NASDAQ Global Select Market
- Shares in Issue
- 32,381,611
- Address
- 52 Sunrise Park Rd, NEW HAMPTON, 10958-4703
- Web
- http://www.balchem.com/
- Phone
- +1 8453265600
- Auditors
- RSM US LLP
Latest News for BCPC
Upcoming Events for BCPC
Q4 2021 Balchem Corp Earnings Release
Q1 2022 Balchem Corp Earnings Release
Balchem Corp Annual Shareholders Meeting
Similar to BCPC
Alico
NASDAQ Global Select Market
Andersons
NASDAQ Global Select Market
Appharvest
NASDAQ Global Select Market
Beyond Meat
NASDAQ Global Select Market
Calavo Growers
NASDAQ Global Select Market
FAQ
What is the Balchem share price?
As of Today at 18:15 UTC, shares in Balchem are trading at $149.75. This share price information is delayed by 15 minutes.
How has the Balchem share price performed this year?
Shares in Balchem last closed at $149.75 and the price had moved by +22.6% over the past 365 days. In terms of relative price strength the Balchem share price has underperformed the S&P500 Index by -0.12% over the past year.
What are the analyst and broker recommendations for Balchem?
The overall consensus recommendation for Balchem is Buy. You can view the full broker recommendation list by unlocking its StockReport.
What is the Balchem dividend yield?
The Balchem dividend yield is 0.39% based on the trailing twelve month period.
Does Balchem pay a dividend?
Last year, Balchem paid a total dividend of $0.58, and it currently has a trailing dividend yield of 0.39%.Looking ahead, the next dividend pay date is 2022-01-21.
When does Balchem next pay dividends?
We do not have data on when Balchem is to next pay dividends. The historic dividend yield on Balchem shares is currently 0.39%.
How do I buy Balchem shares?
To buy shares in Balchem you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Balchem?
As of the previous close price of $149.75, shares in Balchem had a market capitalisation of $4.85bn.
Where are Balchem shares listed?
Here are the trading details for Balchem:
- Country of listing: United States
- Exchange: NSQ
- Ticker Symbol: BCPC
What kind of share is Balchem?
Based on an overall assessment of its quality, value and momentum Balchem is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Balchem share price forecast for 2022?
The analyst consensus target price for shares in Balchem is $169.67. That is 13.3% above the last closing price of $149.75.
Analysts covering Balchem currently have a consensus Earnings Per Share (EPS) forecast of $3.63 for the next financial year.
What is the trend in the Balchem share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Balchem. Over the past six months, its share price has outperformed the S&P500 Index by +9.2%.
As of the last closing price of $149.75, shares in Balchem were trading +4.93% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Balchem PE Ratio?
The Balchem PE ratio based on its reported earnings over the past 12 months is 35.7. The shares last closed at $149.75.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Balchem?
Balchem's management team is headed by:
- Theodore Harris - CHM
- Martin Bengtsson - CFO
- James Hyde - SVP
- William Backus - CAO
- Mark Stach - GCN
- John Televantos - LED
- Kathleen Fish - DRC
- David Fischer - IND
- Daniel Knutson - IND
- Joyce Lee - IND
- Perry Premdas - IND
- Matthew Wineinger - IND